Literature DB >> 28249799

European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy.

Vincenzo Mirone1, Frans Debruyne2, Gert Dohle3, Andrea Salonia4, Nikolaos Sofikitis5, Paolo Verze6, Mikkel Fode7, Christopher Chapple8.   

Abstract

Testosterone is a crucial sex hormone important for the health and development of men of all ages. It plays a role in the integrity and maintaining the function of several systems and organs. Testosterone deficiency is linked to a number of signs and symptoms potentially affecting every man in his complexity and masculinity, and is therefore of strong urological interest. For this reason, urologists should attach importance to the need for knowledge, vocational education, and training in this specific area.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249799     DOI: 10.1016/j.eururo.2017.02.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

2.  Recellularization of testicular feminization testis in C57bl6 as a natural bioreactor for creation of cellularized seminiferous tubules: an experimental study.

Authors:  Shabnam Sabetkish; Abdol-Mohammad Kajbafzadeh; Nastaran Sabetkish
Journal:  Cell Tissue Bank       Date:  2020-11-04       Impact factor: 1.522

3.  Hypogonadotropic Hypogonadism and Kleefstra Syndrome due to a Pathogenic Variant in the EHMT1 Gene: An Underrecognized Association.

Authors:  Ana Patricia Torga; Juanita Hodax; Mari Mori; Jennifer Schwab; Jose Bernardo Quintos
Journal:  Case Rep Endocrinol       Date:  2018-10-02

4.  Do testosterone supplements enhance response to phosphodiesterase 5 inhibitors in men with erectile dysfunction and hypogonadism: a systematic review and meta-analysis.

Authors:  Jun Zhu; Wei Zhang; Ningjing Ou; Yuxuan Song; Jiaqi Kang; Zhen Liang; Rui Hu; Yongjiao Yang; Xiaoqiang Liu
Journal:  Transl Androl Urol       Date:  2020-04

Review 5.  Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations.

Authors:  Milou Cecilia Madsen; Martin den Heijer; Claudia Pees; Nienke R Biermasz; Leontine E H Bakker
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

6.  Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men's Experiences on Prescription Testosterone.

Authors:  Alex A Straftis; Peter B Gray
Journal:  Int J Environ Res Public Health       Date:  2019-09-05       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.